Thursday, June 2, 2022: 5:00 PM-7:00 PM
Prince George's Exhibit Hall (Gaylord National Resort & Convention Center)
Variability of Spasticity in Multiple Sclerosis – Results from SEEN-MSS, a Large-Scale, Self-Reported Survey
Barry Hendin, MD, Center for Neurology and Spine;
Ben W Thrower, MD, Shepherd Center;
Scott D. Newsome, DO, MSCS, FAAN, FANA, Johns Hopkins School of Medicine;
Robert Chinnapongse, MD, Jazz Pharmaceuticals;
Sherry Danese, BS, MBA, Outcomes Insights;
Jenifer Patterson, ARNP, MSCN, Jazz Pharmaceuticals
Current Treatment for Spasticity in Multiple Sclerosis – Satisfaction, Limitations, and Future Directions
Barry Hendin, MD, Center for Neurology and Spine;
Ben W Thrower, MD, Shepherd Center;
Scott D. Newsome, DO, MSCS, FAAN, FANA, Johns Hopkins School of Medicine;
Robert Chinnapongse, MD, Jazz Pharmaceuticals;
Sherry Danese, BS, MBA, Outcomes Insights;
Jenifer Patterson, ARNP, MSCN, Jazz Pharmaceuticals
Fatigue in Active and Nonactive Primary and Secondary Progressive Multiple Sclerosis Patients in the United States
Crystal Watson, MS, Atara Biotherapeutics;
Natalia Sadetsky, MD, PhD, Atara Biotherapeutics;
Dhanalakshmi Thirumalai, PhD, MPH, Atara Biotherapeutics;
Arie Barlev, PharmD, MS, Atara Biotherapeutics;
Nikisha Grant, BSc, MSc, Adelphi Real World;
Eddie Jones, BA, Adelphi Real World;
Sasha Bogdanovich, MD, PhD, Atara Biotherapeutics;
Kiren Kresa-Reahl, MD, Atara Biotherapeutics
Post Hoc Analysis of Nabiximols Efficacy By Concomitant Medication Use in 2 Enriched Placebo-Controlled Randomized Clinical Trials (RCTs)
Faria Amjad, MD, Georgetown University;
Aaron L Boster, MD, The Boster Center for Multiple Sclerosis;
Javier Carod Artal, MD, Raigmore Hospital, NHS Highlands;
Robert Chinnapongse, MD, Greenwich Biosciences, Inc.;
Daniel Checketts, MSc, GW Research Ltd;
Peyman Adjamian, MD, GW Research Ltd;
Joshua R. Steinerman, MD, Greenwich Biosciences, Inc.
